| Financial Year |
March 31 2023 |
| Monetary Funds |
255,163,115.83 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
47,027,180.30 |
| Accounts Receivable |
605,826,074.71 |
| Advances to Suppliers |
136,146,623.62 |
| Other Receivables |
2,213,601.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
348,009,756.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
35,653,594.30 |
| Total Current Assets |
1,458,220,763.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
28,788,586.74 |
| Fixed Assetes |
234,173,747.75 |
| Under-construction Projects |
263,423.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
39,097,478.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
10,851,916.04 |
| Other Non-Current Assets |
19,580,481.26 |
| Sub-Total of Non-Current Assets |
332,755,633.70 |
| Total Assets |
1,790,976,397.54 |
| Short-Term Loans |
220,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
209,746,800.00 |
| Accounts Payable |
129,717,825.97 |
| Accounts Received In Advance |
169,248.13 |
| Employee Compensation Payable |
15,468,031.57 |
| Taxes Payable |
9,782,113.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
25,828,355.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,898,252.31 |
| Sub-Total of Current Liabilities |
640,360,294.18 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
14,681,591.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,259,438.86 |
| Total Liabilities |
658,619,733.04 |
| Paid-In Capital(Or Share Stock) |
165,100,000.00 |
| Capital Surplus |
547,058,505.94 |
| Surplus Reserve |
33,303,795.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
398,104,199.31 |
| Minority Stockholder's Interest |
-11,209,836.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,143,566,500.81 |
| Owner's Equity（Stockholder's Equity） |
1,132,356,664.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,790,976,397.54 |
